Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report)’s stock price traded down 7.1% during mid-day trading on Wednesday . The company traded as low as $17.38 and last traded at $17.4840. 8,867,739 shares were traded during mid-day trading, a decline of 1% from the average session volume of 8,936,462 shares. The stock had previously closed at $18.83.
Key Stories Impacting Amprius Technologies
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Northland Securities raised its FY2028 EPS estimate for Amprius Technologies to $0.23 from $0.20, and also lifted its Q4 2027 estimate to $0.03 from $0.02, signaling improving longer-term profitability expectations.
- Positive Sentiment: Northland Securities’ FY2029 and FY2030 forecasts remain bullish at $0.30 and $0.43 per share, respectively, well above the current consensus estimate for a loss this year.
- Neutral Sentiment: Northland Securities reiterated a long-term improvement path for AMPX, with FY2026 still expected to be a loss at $0.10 per share and FY2027 near breakeven. Amprius Technologies stock page
- Negative Sentiment: Northland Securities trimmed its FY2026 EPS estimate to a loss of $0.10 from a prior loss of $0.08, pointing to a tougher near-term earnings outlook.
- Negative Sentiment: Northland also reduced its Q2 2027 EPS estimate to $0.00 from $0.01, and HC Wainwright cut its FY2026, FY2027, and FY2028 estimates as well, reinforcing concerns that profitability may take longer to arrive.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the company. William Blair reaffirmed an “outperform” rating on shares of Amprius Technologies in a report on Friday, March 6th. Roth Mkm reissued a “buy” rating on shares of Amprius Technologies in a research note on Friday, May 8th. Cantor Fitzgerald increased their target price on Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. B. Riley Financial lifted their price target on Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a report on Monday, March 9th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $20.25.
Amprius Technologies Stock Down 7.1%
The firm has a fifty day moving average of $17.93 and a 200-day moving average of $13.36. The firm has a market cap of $2.40 billion, a P/E ratio of -58.28 and a beta of 2.20.
Amprius Technologies (NYSE:AMPX – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. The business had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. Sell-side analysts anticipate that Amprius Technologies, Inc. will post -0.06 EPS for the current year.
Insider Buying and Selling at Amprius Technologies
In related news, Director Wen Hsuan Hsieh sold 413,146 shares of the company’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the sale, the director owned 44,444 shares in the company, valued at approximately $819,547.36. This represents a 90.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Steven Chu sold 155,565 shares of the firm’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $18.50, for a total value of $2,877,952.50. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. This trade represents a 54.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,539,829 shares of company stock worth $42,323,376 over the last quarter. 5.10% of the stock is currently owned by insiders.
Institutional Trading of Amprius Technologies
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Bank of America Corp DE boosted its stake in Amprius Technologies by 31.1% during the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after acquiring an additional 3,055 shares during the last quarter. Quarry LP bought a new stake in Amprius Technologies in the third quarter valued at approximately $42,000. Rhumbline Advisers increased its stake in Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after purchasing an additional 5,951 shares in the last quarter. Legal & General Group Plc raised its holdings in Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock worth $44,000 after purchasing an additional 9,684 shares during the period. Finally, XTX Topco Ltd acquired a new stake in Amprius Technologies in the second quarter worth $44,000. 5.04% of the stock is owned by institutional investors.
Amprius Technologies Company Profile
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Featured Articles
- Five stocks we like better than Amprius Technologies
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
